Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03427580
Other study ID # MERIT
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 1, 2018
Est. completion date March 2022

Study information

Verified date July 2021
Source Bar-Ilan University, Israel
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

People with schizophrenia spectrum disorders are faced with significant metacognitive impairments that include difficulties in their ability to form complex representations of the self and others. These impairments are associated with increased symptoms, impaired subjective self-experiences, and lower social functioning. As a result, interventions that enhance metacognitive capacity have been recently developed and explored. One of these interventions is Metacognitive Reflection and Insight Therapy (MERIT; Lysaker et al., 2014). MERIT is an integrative model of psychotherapy that seeks to promote holistic metacognitive capacity and consequently increase a positive sense of agency and sense of meaning in life among clients with schizophrenia. Several case studies (including in Bar-Ilan's community clinic), as well as a recent pilot study, showed increased metacognitive abilities and a decrease in symptoms following MERIT. The current study will explore both the effectiveness and the change mechanisms that underlie MERIT interventon among clients diagnosed with schizophrenia spectrum disorders, via both pre- and post-measures of the intervention's outcome and session-by-session estimations of the therapeutic process. **Till now (July 2019) 34 clients have been recruited: 7 clients completed the MERIT therapy; 12 clients are receiving MERIT therapy now days; 6 clients are on the waiting list; 9 dropouts.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date March 2022
Est. primary completion date March 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Diagnosis of schizophrenia spectrum disorders - Ability to provide informed consent - Ability to read and write in Hebrew Exclusion Criteria: - No co-morbid nuerological condition - No hospitalization in the last 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
MERIT
Metacognitive Reflection and Insight Therapy

Locations

Country Name City State
Israel Bar-Ilan University Ramat Gan

Sponsors (1)

Lead Sponsor Collaborator
Bar-Ilan University, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Indiana Psychiatric Illness Interview Interview 45 minutes
Primary Positive and Negative Syndrome Scale Clinician-rated scale 15 minutes
Primary Social Skill Performance Assessment Verbal role-play assessment 15 minutes
Primary Face Emotion Identification Task Questionnaire 5 minutes
Primary Faux-Pas task questionnaire 10 minutes
Primary Ambiguous Intentions Hostility Questionnaire Questionnaire 5 minutes
Primary Heinrichs-Carpenter Quality of Life scale Clinician-rated scale 30 minutes
Primary Beck Depression Inventory-II Questionnaire 5 minutes
Primary Outcome Questionnaire -45 Questionnaire 5 minutes
Primary The Life Regard Index Questionnaire 5 minutes
Primary The Internalized Stigma of Mental Illness scale Questionnaire 5 minutes
Primary Self-compassion Scale Questionnaire 5 minutes
Primary The Self-Concept Clarity scale Questionnaire 5 minutes
Primary Difficulties in Emotion Regulation Scale Questionnaire 5 minutes
Primary The Emotion Regulation Questionnaire Questionnaire 5 minutes